Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Journal of Biological Regulators and Homeostatic Agents|July 20, 2021
Clinical evaluation of efficacy and tolerance of a skin reconditioning compound for anti-agingA Scarano, A Sbarbati, F Deriu, et al.
British Journal of Cancer|August 12, 2004
Phase II trial of carboplatin and etoposide for patients with recurrent high-grade gliomaE Franceschi, G Cavallo, L Scopece, et al.
Lung Cancer (Amsterdam, Netherlands)|April 25, 2006
A randomized phase II trial evaluating standard (50 mg/min) versus low (10 mg/min) infusion duration of gemcitabine as first-line treatment in advanced non-small-cell lung cancer patients who are not eligible for platinum-based chemotherapyF Cappuzzo, S Novello, F De Marinis, et al.
Journal of Telemedicine and Telecare|July 23, 2005
Role of telecardiology in the assessment of angina in patients with recent acute coronary syndromeA Chiantera, S Scalvini, G Pulignano, et al.
British Journal of Cancer|June 16, 2005
Phase II study of gemcitabine plus oxaliplatin as first-line chemotherapy for advanced non-small-cell lung cancerF Cappuzzo, S Novello, F De Marinis, et al.
British Journal of Cancer|January 8, 2004
Multicentric phase II trial of gemcitabine plus epirubicin plus paclitaxel as first-line chemotherapy in metastatic breast cancerF Cappuzzo, F Mazzoni, A Gennari, et al.
British Journal of Cancer|November 17, 2005
HER3 genomic gain and sensitivity to gefitinib in advanced non-small-cell lung cancer patientsF Cappuzzo, L Toschi, I Domenichini, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 12, 2009
Epidemic multidrug-resistant Acinetobacter baumannii related to European clonal types I and II in Rome (Italy)S D'Arezzo, A Capone, N Petrosillo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 8, 2006
Insulin-like growth factor receptor 1 (IGFR-1) is significantly associated with longer survival in non-small-cell lung cancer patients treated with gefitinibF Cappuzzo, L Toschi, G Tallini, et al.
ESMO Open|October 11, 2025
Interaction between tumor-infiltrating lymphocytes and BMI in early HER2-positive breast cancer: analysis of the ShortHER trialM V Dieci, G Bisagni, S Bartolini, et al.
Pageof 4